Sign in
Taking people in United StatesNo phase

Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

Key facts

Who runs it
Ilana Hull
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
28 Aug 2023
Expected to end
1 Dec 2026
Type of study
Observational
Treatments tested
  • Buprenorphine/ Methadone exposure
Record updated
6 August 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Pregnant women with OUD and their infant
  • Currently on BUP/METH for OUD
  • Enrolled in prenatal opioid maintenance program
  • Age >18 years
  • Singleton pregnancy
  • Planned delivery at UPMC's Magee Womans Hospital
  • Positive opioid urine screen results

Who cannot take part

  • Serious maternal medical illness as deemed by the PI that would make it challenging to comply with study procedures
  • HIV or AIDS
  • Known major fetal congenital abnormalities

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Opioid use disorder or pregnancy related

This trial is currently available in United States.

  • UPMC-Magee Womens HospitalPittsburgh, United StatesContact: Ilana Hull, MDTaking people

About the trial

What the trial wants to find out

This study will be a 12-month prospective, genotype-blinded longitudinal observational study with current standard of clinical care. This study will enroll 100 pregnant women with OUD at UPMC Hospitals with its high volumes. Because of the observational nature of the study, the anticipated dropout rate will be ≤ 20%. Investigators expect the effective sample size of evaluable patients will be 200 with longitudinal data.

The group in the trial

  • Pregnant women with Opioid Use Disorder (OUD)

    This study will enroll 100 pregnant women with OUD at UPMC with its high volumes

    Treatment: Buprenorphine/ Methadone exposure

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05942313, who can take part
Record updated
6 August 2026